ArticleAntimicrobial agents and chemotherapy2003

The M184V substitution in human immunodeficiency virus type 1 reverse transcriptase delays the development of resistance to amprenavir and efavirenz in subtype B and C clinical isolates.

Karidia Diallo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.